Keyword: Diabetes


Novo Nordisk to Invest €2.1 Billion in French Production Site

24.11.2023 -

Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more...


Lonza, Vertex Break Ground on New US Cell Therapy Plant

05.09.2023 -

Last week, Lonza and Vertex Pharmaceuticals broke ground on a new US facility in Portsmouth, New Hampshire, to manufacture cell therapies for diabetes.


Novo Nordisk to Acquire Inversago Pharma

11.08.2023 -

Danish drugmaker Novo Nordisk has agreed to acquire Montreal, Canada-based Inversago Pharma. The transaction is worth up to $1.075 billion in cash if certain development...


Vertex Buys ViaCyte for $320 Million

19.07.2022 -

US-based Vertex Pharmaceuticals has agreed to pay $320 million in cash to acquire ViaCyte, a compatriot private cellular therapy company specializing in a treatment for...


Novo Nordisk Gets EU Nod for Diabetes Drug

13.02.2018 - Danish drugmaker Novo Nordisk has been granted marketing approval by the European Commission for its Ozempic (semaglutide) diabetes treatment. The once-weekly drug, a glucagon-like...


Chinese Interest in J&J Diabetes Franchise?

22.01.2018 - Chinese companies are said to be taking great interest in the diabetes care business Johnson & Johnson may put up for sale. The news agency Reuters, citing “five people with direct...

Plant Construction & Process Technology

Bioelectronic Medicines: A New Type of Personalization

27.04.2017 - Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...


Lilly to Invest $850 Million in US Operations

05.04.2017 - US drugmaker Eli Lilly has announced plans to invest $850 million in its US operations during 2017, including an $85 million expansion of its Trulicity (dulaglutide) device...